Sandoz makes new investment in biopharmaceuticals in Slovenia
23.02.2010 | Lek, a Sandoz company, today opened a new facility for production of state-of-the-art biopharmaceutical active substances.

24.09.2009 | Sandoz continues investments in Slovenia

04.09.2009 | Lek’s sponsorship of the Biennial of Graphic Arts helps support art in Slovenia

1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010

Lek, a Sandoz company, Novartis generics business, is an international pharmaceutical company.

From the very beginning, our operations have been characterized by dynamic development and a tendency towards internationalization.

Vojmir Urlep
Zvonko Bogdanovski
Darija Brecevic
Ksenija Butenko Cerne
Markus Delfosse
Bojan Dolenc
Daniel Karrer

Members of the Board of Management
Supervisory Board
Headquarters and Lek's Units
Manufacturing
Medicines
History

Lek's TV and print advertising.